Inventory Overview
This inventory tracks whether major U.S. payers publicly disclose prior authorization and utilization management performance metrics under CMS-0057-F and related transparency requirements. Coverage spans national commercial insurers, PBMs, BCBS plan licensees, ERISA self-insured employer plans, fully insured employer groups, and state Medicaid managed care programs.
National and Regional Commercial Payers
Among national commercial insurers, transparency disclosure quality varies significantly. UnitedHealth Group, CVS Health (Aetna), Cigna (The Cigna Group), and Humana are subject to CMS-0057-F annual reporting for Medicare Advantage and ACA marketplace lines of business. Commercial fully insured group disclosure is less consistent. Centene, Molina, and Elevance Health (Anthem) carry substantial Medicaid managed care exposure with state-specific reporting obligations that differ materially from commercial transparency standards.
The ERISA Self-Insured Employer Blind Spot
Approximately 60 to 65 percent of privately insured Americans are covered through ERISA self-insured employer arrangements. These plans are exempt from state insurance regulation and are not subject to most state-level PA disclosure mandates. CMS-0057-F reporting requirements apply only to plans under CMS oversight, creating a structural transparency blind spot covering the largest single segment of commercially insured lives in the United States. Administrative services only (ASO) arrangements between self-insured employers and commercial insurers mean the same carrier may operate both a regulated and an unregulated PA process across its book of business.
Pharmacy Prior Authorization Gaps
PBMs including CVS Caremark, Express Scripts (Evernorth), and OptumRx manage pharmacy prior authorization separately from medical PA under distinct contractual and regulatory frameworks. Pharmacy PA disclosure requirements are less developed than medical PA requirements. Step therapy, quantity limits, and non-medical switching are common pharmacy PA practices with limited public transparency. CMS-0057-F covers pharmacy benefits for CMS-regulated plans, but enforcement and reporting standards for pharmacy PA metrics lag those for medical PA.
State Regulatory and Enforcement Variability
State-level PA transparency frameworks range from proactive mandatory reporting with public dashboards (California, New York, Colorado) to minimal disclosure requirements beyond federal minimums. States with Gold Carding laws, step therapy reform legislation, independent review organization mandates, or clinical criteria disclosure requirements generally present stronger PA transparency environments for fully insured commercial plans. Medicaid managed care disclosure requirements are established through state contracts with managed care organizations and vary by state.